Harel Insurance Investments & Financial Services’s Juno Therapeutics, Inc. JUNO Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,500	Closed	-$297K	–	505
2017 Q4	$297K	Buy	+6,500	New	+$324K	0.02%	177

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Harel Insurance Investments & Financial Services's JUNO Position: Q1 2018 in Review

Harel Insurance Investments & Financial Services sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 6,500 shares — an estimated $297K sold.

Harel Insurance Investments & Financial Services first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $297K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Harel Insurance Investments & Financial Services reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 6,500 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $297K.
Harel Insurance Investments & Financial Services first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Harel Insurance Investments & Financial Services's Juno Therapeutics, Inc. position peaked at $297K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2018, filed 30 Apr 2018.